CBD Sleep Mask Objectively Proven to Reduce Sprinkles

Here’s the latest CBD News:

  • Innocan Pharma’s CBD-based sleep mask has been proven by a clinical trial to reduce wrinkles. 
  • A prominent cannabis distributor acquires Green Roads, a CBD industry leader.
  • A study finds that CBD can address drug-related behaviors in cocaine-addicted mice.

Table of Contents

  1. CBD Sleep Mask Objectively Proven to Reduce Wrinkles
  2. Valens Company Finalizes Acquisition of Green Roads
  3. Study Shows CBD Modifies Addiction-Related Behaviors In Mice

CBD Sleep Mask Objectively Proven to Reduce Wrinkles

Pharmaceutical tech corporation Innocan Pharma announced this Wednesday (June 24) that their Shir CBD+ Anti-Aging Sleeping Mask was shown to reduce the appearance of wrinkles in a recent clinical trial.

According to the trial data, participants who used the face mask reported up to a 28.8% reduction in visible wrinkles within four or more weeks.

The set of receptors in the body—collectively referred to as the endocannabinoid system—that interact with cannabinoids that our bodies already produce is thought to be involved in skin cell differentiation, growth, function, and death, per Innacan’s website.

Researchers are still uncovering the nature and extent of CBD’s roles in skin health, but results like these point to more product development and research in the future.

Valens Company Finalizes Acquisition of Green Roads

Pharmacist-led Green Roads, a leading CBD brand we reviewed here, has officially been acquired by prominent cannabis manufacturer The Valens Company.

Included in the now finalized deal was the sale of all issued and unissued Green Roads stock for $40 million USD, along with another $20 million contingent upon Green Roads hitting certain milestones in 2022.

The Valens Company CEO and co-founder Tyler Robson described the acquisition as “a monumental step in our internal expansion strategy.”

The acquisition will give The Valens Company a major boost in North American markets. 

A study out of Valencia, Spain published in Progress in Neuropsychopharmacology & Biological Psychiatry on June 19th showed that CBD can “prevent priming-induced reinstatement of CPP (conditioned place preference)” among cocaine-addicted mice. 

In layman terms, cocaine-addicted mice showed a greater reluctance to return to addiction-related behaviors (after being cued towards more cocaine) when given cannabidiol first. 

The researchers also found that “CBD abolished cocaine-induced hyperactivity without altering the spontaneous locomotion of the animals.” 

Finally, cannabidiol also demonstrably decreased the memory loss associated with cocaine withdrawal, which researchers measured with an object recognition test.

In concluding, the authors emphasized that these effects of cannabidiol on cocaine addiction, though promising, were more prominent in the withdrawal phase, which concurs with contemporary studies.